혈장 요법 시장 규모, 점유율, 성장 분석 : 유형별, 공급원별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Plasma Therapy Market Size, Share, Growth Analysis, By Type (Pure PRP, Leukocyte-Rich PRP), By Source (Autologous, Allogenic), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1630784
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 242 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 혈장 요법 시장 규모는 2023년에 3억 1,000만 달러로 평가되며, 2024년 3억 5,433만 달러에서 2032년에는 10억 3,223만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 14.3%로 성장할 전망입니다.
혈장 치료 시장은 안드로겐성탈모증과 스포츠 관련 부상 증가로 인해 성장할 것으로 예상됩니다. 혈장은 높은 항체 농도로 인해 면역 전달을 제공하고, 특히 정형외과, 피부과, 치과에서 혈장의 치료적 용도가 유용합니다. 다양한 치료 분야에서 혈소판풍부혈장(PRP)의 채택이 증가하고 있는 것도 큰 성장 촉매제가 되고 있습니다. 하지만, 혈장 치료와 관련된 다양한 비용, 당뇨병 환자 및 신부전 환자에서 제한된 유효성 등의 문제들이 시장 확대에 걸림돌이 될 수 있습니다. 또한 관절염 환자의 급격한 증가는 시장 성장을 둔화시킬 수 있습니다. 전반적으로 증가하는 환자 수요와 새로운 치료 용도의 결합은 이 분야의 이해관계자들에게 큰 미래 기회를 제공할 것입니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요의 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
사례 연구 분석
혈장 요법 시장 규모 : 유형별
시장 개요
순수 PRP
백혈구 풍부 PRP
순수 혈소판 풍부 피브린
백혈구 풍부 피브린
혈장 요법 시장 규모 : 공급원별
시장 개요
자가
동종
혈장 요법 시장 규모 : 용도별
시장 개요
정형외과
관절염
만성건염
뼈 수복과 재생
피부과
안드로겐성 탈모증
성형 외과
심근 손상
치과
신경 손상
기타
혈장 요법 시장 규모 : 최종사용자별
시장 개요
병원·클리닉
조사기관
혈장 요법 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
회사 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출의 전년대비 비교(2022-2024년)
주요 기업 개요
CSL Behring(Australia)
Grifols S.A.(Spain)
Kedrion S.p.A.(Italy)
Octapharma AG(Switzerland)
Takeda Pharmaceutical Company Limited(Japan)
Zimmer Biomet(US)
Baxter International Inc.(US)
China Biologic Products Holdings, Inc.(China)
GC Pharma(South Korea)
Green Cross Corp.(South Korea)
Japan Blood Products Organization(Japan)
LFB SA(France)
Shanghai RAAS Blood Products Co., Ltd.(China)
China National Biotec Group Co., Ltd.(CNBG)(China)
Global Plasma Therapy Market size was valued at USD 310.0 million in 2023 and is poised to grow from USD 354.33 million in 2024 to USD 1032.23 million by 2032, growing at a CAGR of 14.3% during the forecast period (2025-2032).
The market for plasma therapy is poised for growth, driven by the increasing incidence of androgenic alopecia and sports-related injuries. With plasma's high antibody concentration, its therapeutic application offers immunity transfer, particularly beneficial in orthopaedics, dermatology, and dentistry. The rising adoption of platelet-rich plasma (PRP) across various therapeutic areas is also a significant growth catalyst. However, challenges such as the lack of reimbursement frameworks, varied costs associated with plasma therapy, and limited efficacy in diabetic and kidney-compromised patients may hinder market expansion. Additionally, the surge in arthritis cases could moderate growth. Overall, the convergence of increasing patient demand and emerging treatment applications presents substantial future opportunities for stakeholders in this sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Plasma Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Plasma Therapy Market Segmental Analysis
Global Plasma Therapy Market is segmented by Type, Source, Application, End User and region. Based on Type, the market is segmented into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin. Based on Source, the market is segmented into Autologous and Allogenic. Based on Application, the market is segmented into Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. Based on End User, the market is segmented into Hospitals & Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Plasma Therapy Market
The Global Plasma Therapy market is experiencing significant growth due to several driving factors. A notable increase in the use of platelet-rich plasma (PRP) is attributed to a surge in sports injuries, along with a rising demand for cosmetic procedures, as more individuals engage in athletic activities. Additionally, the expanded application of PRP in research is further propelling the sector forward. As awareness of the benefits of plasma therapy continues to grow, fueled by its effectiveness in healing and rejuvenation, the market is well-positioned for continued expansion, attracting both medical professionals and patients alike.
Restraints in the Global Plasma Therapy Market
The Global Plasma Therapy market faces significant restraints primarily due to the high costs associated with the treatment. The expenses involved in extracting plasma from blood and the subsequent storage requirements pose a challenge to market growth. In both developing and underdeveloped regions, these costs have greatly limited the accessibility and utilization of plasma therapy. As a result, the average individual often finds the treatment financially out of reach, which serves as a major barrier to market expansion. Consequently, the high financial burden associated with plasma therapy remains one of the primary factors hindering its wider adoption and development.
Market Trends of the Global Plasma Therapy Market
The global plasma therapy market is poised for significant growth driven by an increasing prevalence of androgenic alopecia and orthopedic disorders. As healthcare advancements expand treatment options, consumers are now empowered to select therapies aligned with their financial capabilities, thus enhancing market accessibility. Nevertheless, challenges persist, notably the limited application of platelet-rich plasma (PRP) in patients with diabetes and kidney issues, which may hinder market expansion. Additionally, the rise of innovative healthcare technologies is improving treatment efficacy, particularly for rare diseases, fostering increased interest in plasma therapies. Overall, these trends indicate a dynamic future landscape for the plasma therapy market.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis
Global Plasma Therapy Market Size by Type & CAGR (2025-2032)
Market Overview
Pure PRP
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin
Global Plasma Therapy Market Size by Source & CAGR (2025-2032)
Market Overview
Autologous
Allogenic
Global Plasma Therapy Market Size by Application & CAGR (2025-2032)
Market Overview
Orthopedic
Arthritis
Chronic Tendinitis
Bone Repair & Regeneration
Dermatology
Androgenic Alopecia
Plastic Surgery
Cardiac Muscle Injury
Dental
Nerve Injury
Others
Global Plasma Therapy Market Size by End User & CAGR (2025-2032)
Market Overview
Hospitals & Clinics
Research Institutes
Global Plasma Therapy Market Size & CAGR (2025-2032)
North America (Type, Source, Application, End User)
US
Canada
Europe (Type, Source, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Source, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Source, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Type, Source, Application, End User)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
CSL Behring (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Grifols S.A. (Spain)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Kedrion S.p.A. (Italy)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Octapharma AG (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Takeda Pharmaceutical Company Limited (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Zimmer Biomet (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Baxter International Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
China Biologic Products Holdings, Inc. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
GC Pharma (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Green Cross Corp. (South Korea)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Japan Blood Products Organization (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
LFB SA (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Shanghai RAAS Blood Products Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
China National Biotec Group Co., Ltd. (CNBG) (China)
